Advertising Agencies
Compare Stocks
5 / 10Stock Comparison
FLNT vs ACMR vs PERI vs CDLX vs MGNI
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Internet Content & Information
Advertising Agencies
Advertising Agencies
FLNT vs ACMR vs PERI vs CDLX vs MGNI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Advertising Agencies | Semiconductors | Internet Content & Information | Advertising Agencies | Advertising Agencies |
| Market Cap | $82M | $3.92B | $483M | $43M | $2.01B |
| Revenue (TTM) | $209M | $901M | $440M | $206M | $723M |
| Net Income (TTM) | $-27M | $94M | $-8M | $-95M | $159M |
| Gross Margin | 24.5% | 44.4% | 33.3% | 38.9% | 63.4% |
| Operating Margin | -9.7% | 12.1% | -3.4% | -22.8% | 14.8% |
| Forward P/E | — | 29.7x | 8.9x | — | 13.4x |
| Total Debt | $38M | $303M | $42M | $215M | $279M |
| Cash & Equiv. | $13M | $766M | $91M | $49M | $553M |
FLNT vs ACMR vs PERI vs CDLX vs MGNI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Fluent, Inc. (FLNT) | 100 | 23.1 | -76.9% |
| ACM Research, Inc. (ACMR) | 100 | 297.0 | +197.0% |
| Perion Network Ltd. (PERI) | 100 | 195.6 | +95.6% |
| Cardlytics, Inc. (CDLX) | 100 | 1.1 | -98.9% |
| Magnite, Inc. (MGNI) | 100 | 223.3 | +123.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FLNT vs ACMR vs PERI vs CDLX vs MGNI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FLNT lags the leaders in this set but could rank higher in a more targeted comparison.
ACMR carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 30.7% 10Y total return vs PERI's 139.6%
- 15.2% revenue growth vs FLNT's -18.0%
- 0.2% yield; 3-year raise streak; the other 4 pay no meaningful dividend
- +195.6% vs CDLX's -63.8%
PERI is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 0 yrs, beta 0.94
- Lower volatility, beta 0.94, Low D/E 6.3%, current ratio 2.76x
- Beta 0.94, current ratio 2.76x
- Lower P/E (8.9x vs 13.4x)
Among these 5 stocks, CDLX doesn't own a clear edge in any measured category.
MGNI ranks third and is worth considering specifically for growth exposure.
- Rev growth 6.9%, EPS growth 493.8%, 3Y rev CAGR 7.4%
- 22.0% margin vs CDLX's -46.0%
- 5.3% ROA vs FLNT's -34.3%, ROIC 9.5% vs -31.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% revenue growth vs FLNT's -18.0% | |
| Value | Lower P/E (8.9x vs 13.4x) | |
| Quality / Margins | 22.0% margin vs CDLX's -46.0% | |
| Stability / Safety | Beta 0.94 vs ACMR's 3.24, lower leverage | |
| Dividends | 0.2% yield; 3-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +195.6% vs CDLX's -63.8% | |
| Efficiency (ROA) | 5.3% ROA vs FLNT's -34.3%, ROIC 9.5% vs -31.8% |
FLNT vs ACMR vs PERI vs CDLX vs MGNI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FLNT vs ACMR vs PERI vs CDLX vs MGNI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MGNI leads in 2 of 6 categories
PERI leads 2 • ACMR leads 2 • FLNT leads 0 • CDLX leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
MGNI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACMR is the larger business by revenue, generating $901M annually — 4.4x CDLX's $206M. MGNI is the more profitable business, keeping 22.0% of every revenue dollar as net income compared to CDLX's -46.0%. On growth, ACMR holds the edge at +9.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $209M | $901M | $440M | $206M | $723M |
| EBITDAEarnings before interest/tax | -$11M | $126M | $3M | -$23M | $145M |
| Net IncomeAfter-tax profit | -$27M | $94M | -$8M | -$95M | $159M |
| Free Cash FlowCash after capex | -$5M | -$69M | $39M | $6M | $44M |
| Gross MarginGross profit ÷ Revenue | +24.5% | +44.4% | +33.3% | +38.9% | +63.4% |
| Operating MarginEBIT ÷ Revenue | -9.7% | +12.1% | -3.4% | -22.8% | +14.8% |
| Net MarginNet income ÷ Revenue | -13.0% | +10.4% | -1.8% | -46.0% | +22.0% |
| FCF MarginFCF ÷ Revenue | -2.4% | -7.6% | +8.9% | +2.9% | +6.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -5.5% | +9.4% | +5.8% | -44.6% | +5.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +31.6% | -76.1% | +72.7% | +3.8% | +142.9% |
Valuation Metrics
PERI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, MGNI trades at a 66% valuation discount to ACMR's 43.2x P/E. On an enterprise value basis, MGNI's 11.4x EV/EBITDA is more attractive than PERI's 106.0x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $82M | $3.9B | $483M | $43M | $2.0B |
| Enterprise ValueMkt cap + debt − cash | $107M | $3.5B | $434M | $210M | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -2.64x | 43.21x | -56.74x | -0.40x | 14.74x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 29.68x | 8.89x | — | 13.45x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.22x | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 27.49x | 106.04x | — | 11.43x |
| Price / SalesMarket cap ÷ Revenue | 0.39x | 4.35x | 1.10x | 0.18x | 2.81x |
| Price / BookPrice ÷ Book value/share | 3.95x | 2.06x | 0.67x | — | 2.33x |
| Price / FCFMarket cap ÷ FCF | — | — | 12.66x | 4.89x | 12.11x |
Profitability & Efficiency
MGNI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MGNI delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $-9 for CDLX. PERI carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to FLNT's 2.07x. On the Piotroski fundamental quality scale (0–9), CDLX scores 6/9 vs ACMR's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -134.2% | +6.1% | -1.2% | -8.7% | +18.6% |
| ROA (TTM)Return on assets | -34.3% | +3.9% | -0.9% | -31.5% | +5.3% |
| ROICReturn on invested capital | -31.8% | +7.0% | -1.7% | -18.3% | +9.5% |
| ROCEReturn on capital employed | -76.6% | +6.6% | -1.8% | -20.9% | +7.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 2 | 3 | 6 | 6 |
| Debt / EquityFinancial leverage | 2.07x | 0.16x | 0.06x | — | 0.30x |
| Net DebtTotal debt minus cash | $25M | -$463M | -$49M | $167M | -$275M |
| Cash & Equiv.Liquid assets | $13M | $766M | $91M | $49M | $553M |
| Total DebtShort + long-term debt | $38M | $303M | $42M | $215M | $279M |
| Interest CoverageEBIT ÷ Interest expense | -3.74x | 20.44x | — | -14.37x | 4.03x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $23,344 today (with dividends reinvested), compared to $78 for CDLX. Over the past 12 months, ACMR leads with a +195.6% total return vs CDLX's -63.8%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs CDLX's -48.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +9.5% | +31.9% | +15.3% | -30.2% | -12.8% |
| 1-Year ReturnPast 12 months | +19.9% | +195.6% | +16.9% | -63.8% | +12.6% |
| 3-Year ReturnCumulative with dividends | -37.8% | +487.9% | -68.0% | -86.5% | +58.7% |
| 5-Year ReturnCumulative with dividends | -86.6% | +133.4% | -37.2% | -99.2% | -60.9% |
| 10-Year ReturnCumulative with dividends | -90.7% | +3065.8% | +139.6% | -94.2% | -4.7% |
| CAGR (3Y)Annualised 3-year return | -14.6% | +80.5% | -31.6% | -48.8% | +16.7% |
Risk & Volatility
PERI leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
PERI is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than ACMR's 3.24 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PERI currently trades 91.4% from its 52-week high vs CDLX's 23.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.14x | 3.24x | 0.94x | 3.18x | 1.63x |
| 52-Week HighHighest price in past year | $4.15 | $71.65 | $11.79 | $3.28 | $26.65 |
| 52-Week LowLowest price in past year | $1.50 | $19.26 | $8.07 | $0.66 | $10.82 |
| % of 52W HighCurrent price vs 52-week peak | +66.7% | +82.6% | +91.4% | +23.8% | +52.5% |
| RSI (14)Momentum oscillator 0–100 | 38.9 | 60.7 | 59.1 | 36.6 | 55.4 |
| Avg Volume (50D)Average daily shares traded | 33K | 1.2M | 321K | 1.2M | 2.1M |
Analyst Outlook
ACMR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: FLNT as "Hold", ACMR as "Buy", PERI as "Buy", MGNI as "Buy". Consensus price targets imply 29.9% upside for PERI (target: $14) vs -32.4% for ACMR (target: $40). ACMR is the only dividend payer here at 0.19% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | — | Buy |
| Price TargetConsensus 12-month target | $3.50 | $40.00 | $14.00 | — | $18.00 |
| # AnalystsCovering analysts | 2 | 10 | 13 | — | 31 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | — | — | — |
| Dividend StreakConsecutive years of raises | — | 3 | 0 | — | — |
| Dividend / ShareAnnual DPS | — | $0.11 | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +14.7% | 0.0% | +2.3% |
MGNI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PERI leads in 2 (Valuation Metrics, Risk & Volatility).
FLNT vs ACMR vs PERI vs CDLX vs MGNI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FLNT or ACMR or PERI or CDLX or MGNI a better buy right now?
For growth investors, ACM Research, Inc.
(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -18. 0% for Fluent, Inc. (FLNT). Magnite, Inc. (MGNI) offers the better valuation at 14. 7x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FLNT or ACMR or PERI or CDLX or MGNI?
On trailing P/E, Magnite, Inc.
(MGNI) is the cheapest at 14. 7x versus ACM Research, Inc. at 43. 2x. On forward P/E, Perion Network Ltd. is actually cheaper at 8. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — FLNT or ACMR or PERI or CDLX or MGNI?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +133. 4%, compared to -99. 2% for Cardlytics, Inc. (CDLX). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus CDLX's -94. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FLNT or ACMR or PERI or CDLX or MGNI?
By beta (market sensitivity over 5 years), Perion Network Ltd.
(PERI) is the lower-risk stock at 0. 94β versus ACM Research, Inc. 's 3. 24β — meaning ACMR is approximately 243% more volatile than PERI relative to the S&P 500. On balance sheet safety, Perion Network Ltd. (PERI) carries a lower debt/equity ratio of 6% versus 2% for Fluent, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FLNT or ACMR or PERI or CDLX or MGNI?
By revenue growth (latest reported year), ACM Research, Inc.
(ACMR) is pulling ahead at 15. 2% versus -18. 0% for Fluent, Inc. (FLNT). On earnings-per-share growth, the picture is similar: Magnite, Inc. grew EPS 493. 8% year-over-year, compared to -176. 0% for Perion Network Ltd.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FLNT or ACMR or PERI or CDLX or MGNI?
Magnite, Inc.
(MGNI) is the more profitable company, earning 20. 3% net margin versus -44. 4% for Cardlytics, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MGNI leads at 13. 7% versus -20. 2% for CDLX. At the gross margin level — before operating expenses — MGNI leads at 62. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FLNT or ACMR or PERI or CDLX or MGNI more undervalued right now?
On forward earnings alone, Perion Network Ltd.
(PERI) trades at 8. 9x forward P/E versus 29. 7x for ACM Research, Inc. — 20. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PERI: 29. 9% to $14. 00.
08Which pays a better dividend — FLNT or ACMR or PERI or CDLX or MGNI?
In this comparison, ACMR (0.
2% yield) pays a dividend. FLNT, PERI, CDLX, MGNI do not pay a meaningful dividend and should not be held primarily for income.
09Is FLNT or ACMR or PERI or CDLX or MGNI better for a retirement portfolio?
For long-horizon retirement investors, Perion Network Ltd.
(PERI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), +139. 6% 10Y return). Cardlytics, Inc. (CDLX) carries a higher beta of 3. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PERI: +139. 6%, CDLX: -94. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FLNT and ACMR and PERI and CDLX and MGNI?
These companies operate in different sectors (FLNT (Communication Services) and ACMR (Technology) and PERI (Communication Services) and CDLX (Communication Services) and MGNI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FLNT is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; PERI is a small-cap quality compounder stock; CDLX is a small-cap quality compounder stock; MGNI is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 5%
- Gross Margin > 20%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.